Product Launch Market Access July 19-20, 2012 • Loews Hotel • Philadelphia, PA
R e g i s t e r b y m a y 1 1 , 2 0 1 2 a n d R e c e i v e $ 3 0 0 o f f o f Y o u r Registration F e e ! CBI’s 3rd annual bio/Pharmaceutical and medical Device Product Launch Graphic by Getty Images Market access July 19-20, 2012 • loews Hotel • PHiladelphia, Pa Conference Co-Chairs: Ahead-of-the-Curve Strategies to Successfully Launch Ryan Saadi, M.D., World Wide New Products or Indications: Vice President, Health Economics, • understand how a Special Protocol assessment (SPa) may lower the Reimbursement, Strategic Pricing & risk of regulatory rejection Market Access, Cordis Corporation, a Johnson & Johnson Company • hear how AstraZeneca approaches lifecycle management for mid- to late-stage assets Sam Rasty, Vice President, • Discuss top influencers on payer decision making and specialty New Products, pharmacy management with Excellus Blue Cross Blue Shield, Shire HGT Community Specialty Pharmacy Network and MedImpact • integrate launch planning across global affiliates 15+ Industry Experts Share Best Practices • analyze key inputs to determine price and the impact on a product’s commercial success and Case Studies from Companies Including: • hear how Novartis weighs different types of data when determining the product development path astraZeneca novartis Pharmaceuticals corporation • understand how ViroPharma integrated commercial analytics to right-size their sales force and ensure a successful ultra-orphan product launch iSTA Pharmaceuticals ethicon endo-Surgery, inc. PLUS! Genzyme choose between Two Interactive Workshops: onconova therapeutics A: Product Commercialization Simulation eisai ViroPharma B: Effective Reimbursement Planning and Integration into Product Pricing and Launch Design endo Pharmaceuticals medimmune Content.
[Show full text]